JPRN-C000000119
Unknown
未知
Gene evaluation for antihypertensive drug effects study - GEANE study
ational Cardiovascular Center0 sites300 target enrollmentSeptember 7, 2005
Conditionsessential hypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- essential hypertension
- Sponsor
- ational Cardiovascular Center
- Enrollment
- 300
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •severe hypertension (more than 180 and/or 110 mmHg) secondary hypertension female with pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pharmacogenomics and essential hypertensioCardiovascular: HypertensionCirculatory SystemHypertensionISRCTN65522010Department of Health (UK)400
Active, not recruiting
Phase 1
Pharmacogenetics of hypertension: study with Spironolactone or TorasemideEUCTR2020-001014-37-ITOSPEDALE SAN RAFFAELE144
Completed
Phase 4
A study of drugs given in hypertension and evaluation of cardiovascular risk in hypertensive post-menopausal womeHealth Condition 1: null- HYPERTENSIOCTRI/2017/06/008779Govt Medical College Patiala300
Completed
Not Applicable
Antihypertensive Drug/Gene Interactions and CV EventsCardiovascular DiseasesHeart DiseasesMyocardial InfarctionHypertensionCerebrovascular AccidentNCT00005332University of Washington
Completed
Phase 4
Pharmacogenomic Evaluation of Antihypertensive Responses 2HypertensionNCT01203852University of Florida839